Thalidomide improves response rate, survival in multiple myeloma

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1569, 2007-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Thalidomide in multiple myeloma

By García-Sanz Ramón

Expert Opinion on Pharmacotherapy, Vol. 7, Iss. 2, 2006-02 ,pp. : 195-213

Informa Healthcare

Access to resources Recommend Favorite

Thalidomide in Multiple Myeloma

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 6, 2006-12 ,pp. : 431-440

Bentham Science Publishers

Access to resources Recommend Favorite

Lovastatin and thalidomide have a combined effect on the rate of multiple myeloma cell apoptosis in short term cell cultures

By Dmoszynska Anna Podhorecka Monika Klimek Piotr Grzasko Norbert

European Journal of Clinical Pharmacology, Vol. 62, Iss. 4, 2006-04 ,pp. : 325-329

Springer Publishing Company

Access to resources Recommend Favorite

Thalidomide benefits patients with refractory multiple myeloma

Inpharma, Vol. 1, Iss. 1342, 2002-01 ,pp. : 17-17

Adis International

Access to resources Recommend Favorite

Thalidomide as an Antiangiogenic Drug in the Treatment of Multiple Myeloma

Letters in Drug Design & Discovery, Vol. 1, Iss. 2, 2004-04 ,pp. : 135-136

Bentham Science Publishers

Access to resources Recommend Favorite